View printer-friendly version << Back

Novavax to Participate in the Citi 2016 Global Healthcare Conference

GAITHERSBURG, Md., Nov. 30, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in the Citi 2016 Global Healthcare Conference.

Conference details are as follows:

Date: Wednesday, December 7, 2016
Location: New York Palace Hotel, New York, New York

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website,


Novavax, Inc.Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

Russo Partners, LLCDavid SchullTodd Davenport, Ph.D.

Primary Logo

Novavax, Inc.